There has been a rapid increase in our understanding of the cellular compon
ents of the innate immune system, the receptors used to distinguish changes
in homeostasis, and how these components integrate into an anti-tumor effe
ctor response. Recently, significant progress has been made in the identifi
cation of ligands for receptors that activate NK cells, and the results hav
e implications for the recognition of tumor cells.